glp 1 tirzepatide zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly's GLP-1 outdoes Novo

This mechanism underlies the interest in GHRH-based peptides for visceral fat reductiona topic explored in clinical trials with Tesamorelin, which has FDA approval for HIV-associated lipodystrophy

Dual GLP-1/glucagon agonists such as survodutide have demonstrated substantial hepatic fat reduction and MASH improvement, though tolerability optimization may be needed

Men with existing medical conditions or those taking medications should consult with healthcare providers before beginning peptide therapy

Current litigation involving GLP-1 medications focuses primarily on severe gastrointestinal injuries, including gastroparesis, ileus, and intestinal obstruction, as well as emerging reports of possible vision loss in certain patients

Mol (Basel, Switz)